A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy

JOURNAL ARTICLE published September 2016 in Lung Cancer

Authors: Kiyotaka Yoh | Yukio Hosomi | Kazuo Kasahara | Kazuhiko Yamada | Toshiaki Takahashi | Nobuyuki Yamamoto | Makoto Nishio | Yuichiro Ohe | Toshiko Koue | Takashi Nakamura | Sotaro Enatsu | Pablo Lee | David Ferry | Tomohide Tamura | Kazuhiko Nakagawa